10x Genomics, Inc. provided earnings guidance for the third quarter of 2025. For the period, the company expects revenue to be in the range of $140 million to $144 million. This guidance reflects approximately $4.0 million of revenue that resulted from customers in China accelerating
purchases from the third quarter into the second quarter in anticipation of potential tariff changes.